1322.6000 -7.40 (-0.56%)
NSE Apr 08, 2026 10:24 AM
Volume: 722.8K
 

Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. has an average target of 1362.22 from 9 brokers.
More from Aurobindo Pharma Ltd.
Recommended